Cancer Immunotherapy Treatment in Germany

Biotherapy International — Partner Clinic in Rheinfelden, Germany

The Biotherapy International partner clinic in Germany is located in the city of Rheinfelden, near the Swiss border. Here, patients gain access to innovative cancer immunotherapy and regenerative medicine programs developed under the direction of Professor Shimon Slavin, M.D. This collaboration provides patients from Europe and around the world with access to individualized treatment based on Biotherapy International protocols.

Biotherapy International Germany branch

Cancer Immunotherapy in Germany

At the partner clinic in Germany, cancer immunotherapy programs are designed for patients who require individualized treatment approaches when standard therapies have reached their limits. In Germany, innovative immunotherapies are accessible through the individual treatment framework, allowing patients to access advanced immunotherapy methods aimed at supporting their treatment course and quality of life.

Cancer Immunotherapy Methods We Utilize in Germany

  • Oncolytic viruses. Human-safe oncolytic viruses that bind to tumor receptors, trigger the destruction of malignant cells, and make them recognizable to the immune system.
  • Cancer vaccines. Personalized cancer vaccines that stimulate the patient’s own immune system to target and destroy cancer cells.
  • ATACK. Allogeneic Targeted Activated Cancer Killer cells – intentionally mismatched cells designed to directly destroy tumors resistant to other treatments.
  • Photodynamic therapy. Also known as PDT, this light-activated treatment uses photosensitizing agents to selectively damage cancer cells while sparing surrounding healthy tissue.

Cancer Types Treated with Immunotherapy in Germany

Our individualized cancer immunotherapy programs in Germany may be considered for patients with different types of advanced or recurrent cancer. The choice and combination of immunotherapy approaches depend on the tumor type, biological and molecular characteristics, previous treatment, disease extent, and the patient’s clinical condition. Treatment methods may be used alone or in combination, with the protocol selected individually after medical evaluation.

Brain tumors

Brain cancer, particularly glioblastoma, is one of Biotherapy International’s main areas of specialization. For selected patients, individualized treatment may include oncolytic virus therapy, personalized cancer vaccines, and cellular immunotherapy, with local or intrathecal administration considered when clinically appropriate.

Other Cancer Types

Mesenchymal Stem Cell (MSC) Therapy in Germany

Mesenchymal stem cell (MSC) therapy is used in regenerative medicine because of the cells’ immunomodulatory and regenerative properties. In Germany, MSC-based treatment may be considered for selected patients with neurodegenerative, autoimmune, and other chronic conditions.

Depending on the clinical situation, treatment may involve autologous stem cells, obtained from the patient, or allogeneic stem cells from a donor source. The choice of cell type and route of administration depends on the diagnosis, disease characteristics, previous treatment, and the patient’s overall condition.

Before treatment, medical records are reviewed to determine whether stem cell therapy may be appropriate and which approach can be considered.

Treatment is generally performed on an outpatient basis and usually requires a short stay in Germany. Follow-up recommendations depend on the condition being treated and the individual treatment protocol.

Treatment at Our Partner Clinic in Germany

Treatment programs are individually planned by Biotherapy International and carried out by the local medical team at the partner clinic in Germany, in accordance with the clinical and regulatory requirements applicable at the clinic.

Q&A

What types of cancer immunotherapy are available at the German clinic?
Depending on the clinical case, the individualized protocol may include oncolytic virus therapy, the ATACK method, photodynamic therapy (PDT), personalized cancer vaccines, and other methods.
Are international patients accepted in Germany?
Yes. Patients from any country can receive treatment at the German partner clinic after completing an online consultation and receiving a personalized protocol.
How is the treatment schedule organized?
After the consultation, the patient receives an individualized protocol describing the recommended procedures, timeframes, and expected treatment duration. Our coordinators arrange all necessary steps with the German clinic and provide logistical support to the patient.
Do patients need to stay in Germany for the entire treatment period?
Not always. For cancer immunotherapy, most patients stay in Germany for 8–15 days, depending on the protocol. For mesenchymal stem cell (MSC) therapy, the visit is significantly shorter and typically takes about 3 days. The exact schedule is determined by the individual treatment plan.
Is Professor Slavin physically present during treatment in Germany?
No. The procedures are performed by the medical team at the partner clinic. Professor Slavin remains responsible for the treatment plan, provides remote supervision, and adjusts the protocol when necessary.
Contact Us